Morgan Stanley Rx Sight, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Rx Sight, Inc. stock. As of the latest transaction made, Morgan Stanley holds 392,199 shares of RXST stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

392,199

Previous 486,900 19.45%

Holding current value

$11.1 Million

Previous $24.1 Million 43.98%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$33.66 - $54.73 $3.19 Million - $5.18 Million	-94,701 Reduced 19.45%	392,199 $13.5 Million
Q3 2024 Nov 14, 2024	SELL	$40.78 - $57.04 $25.7 Million - $36 Million	-630,358 Reduced 56.42%	486,900 $24.1 Million
Q2 2024 Oct 17, 2024	SELL	$50.42 - $64.29 $423,175 - $539,585	-8,393 Reduced 0.75%	1,117,258 $67.2 Million
Q2 2024 Aug 14, 2024	SELL	$50.42 - $64.29 $423,175 - $539,585	-8,393 Reduced 0.75%	1,117,258 $67.2 Million
Q1 2024 Oct 17, 2024	BUY	$35.51 - $57.92 $298,035 - $486,122	8,393 Added 0.75%	1,125,651 $58.1 Million
Q1 2024 Aug 16, 2024	BUY	$35.51 - $57.92 $1.87 Million - $3.05 Million	52,589 Added 4.9%	1,125,651 $58.1 Million
Q1 2024 May 15, 2024	BUY	$35.51 - $57.92 $1.87 Million - $3.05 Million	52,589 Added 4.9%	1,125,651 $58.1 Million
Q4 2023 Aug 16, 2024	SELL	$20.91 - $40.9 $924,138 - $1.81 Million	-44,196 Reduced 3.96%	1,073,062 $43.3 Million
Q4 2023 Feb 13, 2024	SELL	$20.91 - $40.9 $2.89 Million - $5.66 Million	-138,342 Reduced 11.42%	1,073,062 $43.3 Million
Q3 2023 Nov 15, 2023	SELL	$27.05 - $33.37 $8 Million - $9.87 Million	-295,671 Reduced 19.62%	1,211,404 $33.8 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $23.8 Million - $42 Million	1,451,598 Added 2616.58%	1,507,075 $43.4 Million
Q1 2023 May 15, 2023	BUY	$12.58 - $16.68 $402,660 - $533,893	32,008 Added 136.38%	55,477 $925,000
Q4 2022 Feb 14, 2023	SELL	$9.93 - $14.2 $37,088 - $53,037	-3,735 Reduced 13.73%	23,469 $297,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $198,152 - $280,671	17,708 Added 186.48%	27,204 $326,000
Q2 2022 Oct 27, 2022	BUY	$10.61 - $16.66 $63,278 - $99,360	5,964 Added 168.86%	9,496 $134,000
Q2 2022 Aug 15, 2022	BUY	$10.61 - $16.66 $63,278 - $99,360	5,964 Added 168.86%	9,496 $134,000
Q1 2022 Oct 27, 2022	SELL	$8.97 - $14.03 $53,497 - $83,674	-5,964 Reduced 62.81%	3,532 $44,000
Q1 2022 May 13, 2022	BUY	$8.97 - $14.03 $13,589 - $21,255	1,515 Added 75.11%	3,532 $44,000
Q4 2021 Feb 14, 2022	BUY	$9.52 - $13.81 $4,550 - $6,601	478 Added 31.06%	2,017 $23,000
Q3 2021 Nov 15, 2021	BUY	$11.85 - $17.32 $18,237 - $26,655	1,539 New	1,539 $19,000

Others Institutions Holding RXST

# of Institutions

222

Shares Held

33.4M

Call Options Held

531K

Put Options Held

50.1K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $784M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account